These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 9396080
1. Nitric oxide reduces myocardial contractility in isoproterenol-stimulated rat hearts by a mechanism independent of cyclic GMP or cyclic AMP. Weiss HR, Sadoff JD, Scholz PM, Klabunde RE. Pharmacology; 1997 Oct; 55(4):202-10. PubMed ID: 9396080 [Abstract] [Full Text] [Related]
2. Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts. Klabunde RE, Tse J, Weiss HR. Cardiovasc Res; 1998 Mar; 37(3):676-83. PubMed ID: 9659451 [Abstract] [Full Text] [Related]
3. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts. Leone RJ, Straznicka M, Scholz PM, Weiss HR. Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543 [Abstract] [Full Text] [Related]
4. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts. Naim KL, Rabindranauth P, Weiss HR, Tse J, Leone RJ, Scholz PM. Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398 [Abstract] [Full Text] [Related]
5. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle. MacDonell KL, Diamond J. Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291 [Abstract] [Full Text] [Related]
6. NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Klabunde RE, Kimber ND, Kuk JE, Helgren MC, Förstermann U. Eur J Pharmacol; 1992 Nov 13; 223(1):1-7. PubMed ID: 1335873 [Abstract] [Full Text] [Related]
7. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Ebihara Y, Karmazyn M. Cardiovasc Res; 1996 Sep 13; 32(3):622-9. PubMed ID: 8881523 [Abstract] [Full Text] [Related]
11. Nitric oxide as a positive inotropic agent in isolated rat hearts. Kamelgard J, Crestanello JA, Fullerton D, Whitman GJ. J Surg Res; 1995 Oct 13; 59(4):482-4. PubMed ID: 7564321 [Abstract] [Full Text] [Related]
12. The role of endocardial endothelium in the modulation of myocardial contraction in the isolated whole heart. Fort S, Lewis MJ, Shah AM. Cardioscience; 1993 Dec 13; 4(4):217-23. PubMed ID: 7507721 [Abstract] [Full Text] [Related]
13. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP. Moalem J, Weiss HR, Davidov T, Rodriguez R, Molino B, Lazar MJ, Scholz PM. J Surg Res; 2006 Aug 13; 134(2):300-6. PubMed ID: 16545395 [Abstract] [Full Text] [Related]
17. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Paulus WJ, Vantrimpont PJ, Shah AM. Circulation; 1994 May 13; 89(5):2070-8. PubMed ID: 7910117 [Abstract] [Full Text] [Related]
18. Role of nitric oxide in cardiac beta-adrenoceptor-inotropic response. Sterin-Borda L, Genaro A, Perez Leiros C, Cremaschi G, Vila Echagüe A, Borda E. Cell Signal; 1998 Apr 13; 10(4):253-7. PubMed ID: 9617482 [Abstract] [Full Text] [Related]
19. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP. Wilson PS, Thompson WJ, Moore TM, Khimenko PL, Taylor AE. J Surg Res; 1997 Jun 13; 70(1):75-83. PubMed ID: 9228932 [Abstract] [Full Text] [Related]